Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond
Brian S. Barnett, Sarah E. Wakeman, Corey S. Davis, Jamie Favaro, Josiah D. Rich
Abstract
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Massachusetts General Hospital, and the Department of Medicine, Harvard Medical School, Boston. Corey S. Davis is with The Network for Public Health Law, Los Angeles, CA. Jamie Favaro is with NEXT Distro, New York, NY. Josiah D. Rich is with the Departments of Medicine and Epidemiology, Brown University, and the Center for Health and Justice Transformation, The Miriam Hospital, Providence, RI.CopyRightCorrespondence should be sent to Brian S. Barnett, MD, Department of Psychiatry, Lutheran Hospital, 1730 W 25th St, Floor 5E, Cleveland, OH 44113 (e-mail: [email protected]). Reprints can be ordered at http://www.ajph.org by clicking the "Reprints" link.CONTRIBUTORSB. S. Barnett originated the editorial and wrote the first draft. S. E. Wakeman, C. S. Davis, J. Favaro, and J. D. Rich assisted in the development of the concept and helped revise the editorial. https://doi.org/10.2105/AJPH.2021.306228 Accepted: February 06, 2021 Published Online: May 05, 2021